| Assessment Status | Rapid Review Complete |
| HTA ID | 22071 |
| Drug | Estriol |
| Brand | Blissel® |
| Indication | Estriol (Blissel®) 50 micrograms per gram is indicated for local treatment of vaginal dryness in post- menopausal women with vaginal atrophy. |
| Assessment Process | |
| Rapid review commissioned | 05/12/2022 |
| Rapid review completed | 23/01/2023 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that Blissel® not be considered for reimbursement at the submitted price*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.
